TCT-4 Transcatheter Tricuspid Valve Repair in Patients With Functional Tricuspid Regurgitation: 2-Year Outcomes From the FORMA US Early Feasibility Study

Susheel Kodali,Rebecca T. Hahn,Vasilis Babaliaros,Stamatios Lerakis,Vinod H. Thourani,Raj Makkar,Siddharth Singh,Mackram F. Eleid,Vuyisile T. Nkomo,Sorin V. Pislaru,John M. Brown,Robert Kipperman,Leo Marcoff,Isaac George,Chet Rihal,Martin B. Leon

TCT-4 Transcatheter Tricuspid Valve Repair in Patients With Functional Tricuspid Regurgitation: 2-Year Outcomes From the FORMA US Early Feasibility Study

2019

Susheel Kodali
Rebecca T. Hahn
Vasilis Babaliaros
Stamatios Lerakis
Vinod H. Thourani
Raj Makkar
Siddharth Singh
Mackram F. Eleid
Vuyisile T. Nkomo
Sorin V. Pislaru
John M. Brown
Robert Kipperman
Leo Marcoff
Isaac George
Chet Rihal
Martin B. Leon

New transcatheter devices are being developed to reduce tricuspid regurgitation (TR) and improve clinical outcomes in selected patients. The FORMA early feasibility study (EFS) was conducted to evaluate the safety and device performance of the FORMA system (Edwards Lifesciences, Irvine, California

Keywords:

TRICUSPID VALVE REPAIR
Functional tricuspid regurgitation
Cardiology
Internal medicine
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations